載入...
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort
BACKGROUND: MammaPrint is a prognostic assay based on gene expression in tumors from patients with early breast cancer. MammaPrint has been extensively validated and Food and Drug Administration cleared in fresh and formalin-fixed and paraffin-embedded (FFPE) tissue. We aimed to assess its prognosti...
Na minha lista:
| 發表在: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807937/ https://ncbi.nlm.nih.gov/pubmed/33399073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2020.100006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|